⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMVT News
Immunovant, Inc. Common Stock
Form 8-K
sec.gov
IMVT
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
prnewswire.com
IMVT
Form 8-K
sec.gov
IMVT
ROIV
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
globenewswire.com
IMVT
ROIV
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
globenewswire.com
ROIV
IMVT
Wheeler Bio Appoints Rajesh Beri, Ph.D., as Chief Development Officer
prnewswire.com
IMVT
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
globenewswire.com
IMVT
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
globenewswire.com
BIIB
AMGN
BMY
IMVT
AZN
MRK
CTNT
REGN
GILD
Myasthenia Gravis Clinical Trial Pipeline Expands as 25+ Companies Race to Redefine Myasthenia Gravis Treatment Landscape | DelveInsight
globenewswire.com
IMVT
ROIV
MRK
NVS
REGN
UCB
JNJ
ARGX
AMGN
VIR
IPHA
ARWR
APLS
CABA
Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine
globenewswire.com
LLY
NTHI
IMVT
SRPT